-+ 0.00%
-+ 0.00%
-+ 0.00%

BlossomHill Therapeutics Q2 EPS $(8.75)

Benzinga·09/18/2026 11:08:20
Listen to the news

BlossomHill Therapeutics (NASDAQ:BLSM) reported quarterly losses of $(8.75) per share. This is a 58.8 percent decrease over losses of $(5.51) per share from the same period last year.